Global and Japan Coronary Artery Bypass Graft Market Is Expanding Due To Increasing Incidences Of Cardiovascular Diseases

Market overview:

A Coronary Artery Bypass Graft (CABG) is a surgical procedure to restore a person's heart function. The procedure typically takes three to six hours and it involves making an incision in the chest or sternum. A surgeon will then separate the internal mammary artery from the chest wall, radial artery from the arm, and vein from the leg. The surgeon will then attach a bypass vessel to the coronary artery. This procedure may be followed by hypothermia to stop the heart temporarily. The amount of blood vessels used depends on the extent of coronary artery disease and how narrow the vessels are. Coronary angioplasty is another treatment option.

𝐓𝐨 𝐆𝐞𝐭 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐆𝐫𝐚𝐛 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐇𝐞𝐫𝐞: https://bit.ly/3pmtudB

Drivers:

Rising adoption of endoscopic surgeries and is estimated to drive growth of the global and Japan coronary artery bypass graft market over the forecast period. For instance, according to the Centers for Disease Control and Prevention, revealed that 697,000 individuals weresuffering from heart diseases in 2020, and it l out of 5 people lost their lives to these diseases. Moreover, growing prevalence of cardiovascular diseases like Coronary Artery Disease is anticipated to propel growth of the global and Japan coronary artery bypass graft market over the forecast period.

Restraints:

Increasing cost of surgery and lack of regulatory approvals is estimated to hamper growth of the global and Japan coronary artery bypass graft market over the forecast period.

Regional Analysis:

North America is estimated to witness robust growth in the global and Japan coronary artery bypass graft market over the forecast period, due to rising prevalence of cardiovascular diseases. Moreover, Asia Pacific is estimated to witness significant growth in the global and Japan coronary artery bypass graft market over the forecast period, due to rise in awareness among patients regarding various diseases.

Key Players:

Major players in global and Japan coronary artery bypass graft market are MAQUET Holding B.V. & Co.KG, Medtronic, Genesee Biomedical Inc, TERUMO CORPORATION, Edwards Lifesciences, Guidant Group, Novadaq Technologies Inc, KARL STORZ GmbH and Co. KG and Vitalitec International, Inc.

In June 2021, the WHO had launched a list of medical devices to be used in priority in case of diabetes and cardiovascular diseases. This list includes almost 500 medical devices to be used for managing stroke, hypo or hyperglycemic condition and cardiac arrest.